Srinivas Akkaraju - Insider Trading & Ownership

Entity
Individual
Location
565 Everett Avenue, Palo Alto, California
Summary
The estimated net worth of Srinivas Akkaraju is at least $143 M dollars as of July 1, 2024. Srinivas Akkaraju is the Director, 10%+ Owner of Mineralys Therapeutics, Inc. and owns shares of Mineralys Therapeutics, Inc. (MLYS) stock worth about $68.5 M. Srinivas Akkaraju is the Director of Scholar Rock Holding Corp and owns shares of Scholar Rock Holding Corp (SRRK) stock worth about $61.1 M. Srinivas Akkaraju is the Director, 10%+ Owner of vTv Therapeutics Inc. and owns shares of vTv Therapeutics Inc. (VTVT) stock worth about $13 M. Srinivas Akkaraju is the Director of Syros Pharmaceuticals, Inc. and owns shares of Syros Pharmaceuticals, Inc. (SYRS) stock worth about $52.8 K.
All Insider Reports
All Insider Reports

Ownership of Srinivas Akkaraju

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
MLYS Mineralys Therapeutics, Inc. Director, 10%+ Owner $68.5 M May 22, 2024
SRRK Scholar Rock Holding Corp Director $61.1 M +$15 M +32.5% Jun 27, 2024
VTVT vTv Therapeutics Inc. Director, 10%+ Owner $13 M Feb 27, 2024
SYRS Syros Pharmaceuticals, Inc. Director $52.8 K +$4 M Jun 5, 2024
ALMS ALUMIS INC. Director Jul 1, 2024
KDNY CHINOOK THERAPEUTICS, INC. Director Aug 11, 2023
ICPT INTERCEPT PHARMACEUTICALS, INC. Director Nov 8, 2023
JYAC Jiya Acquisition Corp. Director, 10%+ Owner Sep 23, 2022

Insider Transactions Reported by Srinivas Akkaraju:

Sym Company Class Transaction % Value $ Price $ Shares Shares After Date Ownership